Hopt U T, Büsing M, Schareck W D, Becker H D
Department of Surgery, Eberhard-Karls-University, Tübingen, FRG.
Diabetologia. 1991 Aug;34 Suppl 1:S24-7. doi: 10.1007/BF00587614.
Starting in 1987 renal- and pancreaticoduodenal--transplantations were performed simultaneously in a consecutive series of 40 patients with Type 1 diabetes mellitus and end-stage renal disease. Exocrine secretion of the pancreatic graft does not seem to be a crucial problem anymore when using the bladder drainage technique. No pancreatic fistulae were seen. No graft lost its function due to early post-operative graft thrombosis. Early post-operative graft pancreatitis and recurrent urinary tract infections remain the drawbacks of the bladder drainage technique. Despite a strong immunestimulation of the recipient by the combined pancreaticoduodenal/renal allograft all but two rejection episodes could be reversed by using different monoclonal/polyclonal antibodies. Actuarial 1-year-graft survival rate reaches 85% for the pancreas as well as the kidney. Thus, simultaneous pancreas-kidney transplantation can be performed with a high success rate when using the technique described.
自1987年起,对40例1型糖尿病合并终末期肾病患者连续进行了肾和胰十二指肠联合移植。采用膀胱引流技术时,胰腺移植物的外分泌似乎不再是一个关键问题。未发现胰瘘。没有移植物因术后早期移植物血栓形成而失去功能。术后早期移植物胰腺炎和复发性尿路感染仍然是膀胱引流技术的缺点。尽管胰十二指肠/肾联合同种异体移植对受者有强烈的免疫刺激,但除两例排斥反应外,使用不同的单克隆/多克隆抗体均可逆转。胰腺和肾脏的1年移植存活率均达到85%。因此,采用所述技术进行胰肾联合移植可获得较高的成功率。